First of all, we detected no activating mutation of CTNNB1 in FAP-HCA, and—consistent with this finding—there is no nuclear beta-catenin accumulation in any of the HCA cells, as it is otherwise consistently found in HCA with homogenous, strong GS overexpression. The gene discussed is FAP; the disease is hepatocellular adenoma.